ML-211

CAS No. 2205032-89-7

ML-211( —— )

Catalog No. M23993 CAS No. 2205032-89-7

ML-211 is a carbamate-based dual inhibitor of LYPLA1 (IC50 = 17 nM) and the related LYPLA2 (IC50 = 30 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 231 In Stock
5MG 250 In Stock
10MG 359 In Stock
25MG 620 In Stock
50MG 852 In Stock
100MG 1144 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ML-211
  • Note
    Research use only, not for human use.
  • Brief Description
    ML-211 is a carbamate-based dual inhibitor of LYPLA1 (IC50 = 17 nM) and the related LYPLA2 (IC50 = 30 nM).
  • Description
    ML-211 is a carbamate-based dual inhibitor of LYPLA1 (IC50 = 17 nM) and the related LYPLA2 (IC50 = 30 nM).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    LYPLA1|LYPLA2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2205032-89-7
  • Formula Weight
    418.5
  • Molecular Formula
    C25H30N4O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    CC(C)(C)C1CCN(CC1)C(=O)N2N=CC(=N2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Adibekian A , Martin B R , Chang J W , et al. Characterization of a Selective, Reversible Inhibitor of Lysophospholipase 2 (LYPLA2)[J]. National Center for Biotechnology Information (US), 2010.
molnova catalog
related products
  • β-Casomorphin (1-6) ...

    β-Casomorphin (1-6) (bovine)

  • (S,R,S)-AHPC-PEG4-N3

    (S,R,S)-AHPC-PEG4-N3 is a synthesized E3 ligase ligand-linker conjugate that incorporates the (S,R,S)-AHPC based VHL ligand and 4-unit PEG linker used in PROTAC technology.

  • ALX 40-4C Trifluoroa...

    Alx40-4C trifluoroacetate is a chemokine receptor (CXCR4) inhibitor, which inhibits the binding of sdf-1 to CXCR4.Alx40-4ctrifluoroacetate was also an APJ receptor antagonist with an IC50 value of 2.9 M.